| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Department of Veterans Affairs |
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000312 |
Purpose
The purpose of this study is to evaluate alterations in the serotonergic system in cocaine addicts and attempt to dissociate changes secondary to cocaine use from those associated with premorbid characteristics.
| Condition | Intervention | Phase |
|
Cocaine-Related Disorders |
Drug: M-CPP |
Phase I |
| Drug Information available for: | 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Alterations in Serotonergic Functions in Cocaine Addicts |
Eligibility
| Ages Eligible for Study: | 25 Years to 50 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations More Information
| Study ID Numbers: | NIDA-09468-1, R01-09468-1 |
| First Received: | September 20, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000312 |
| Health Authority: | United States: Federal Government |
|
|
